• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

19 de April de 2018
Dis Model Mech. 2018 May 18;11(5):dmm032292. doi: 10.1242/dmm.032292.ABSTRACTUnderstanding…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-04-19 10:00:002018-04-19 10:00:00Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer

18 de April de 2018
Oncotarget. 2018 Mar 23;9(22):15968-15983. doi: 10.18632/oncotarget.24641.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2018-04-18 10:00:002018-04-18 10:00:00Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer

Silibinin is a direct inhibitor of STAT3

17 de April de 2018
Food Chem Toxicol. 2018 Jun;116(Pt B):161-172. doi: 10.1016/j.fct.2018.04.028.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-04-17 10:00:002018-04-17 10:00:00Silibinin is a direct inhibitor of STAT3

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

6 de April de 2018
Clin Cancer Res. 2018 Aug 1;24(15):3755-3766. doi: 10.1158/1078-0432.CCR-17-1898.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-04-06 10:00:002018-04-06 10:00:00Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

6 de April de 2018
Clin Cancer Res. 2018 Aug 1;24(15):3755-3766. doi: 10.1158/1078-0432.CCR-17-1898.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-04-06 10:00:002018-04-06 10:00:00Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Assessment of extracellular matrix-related biomarkers in patients with lower extremity artery disease

5 de April de 2018
J Vasc Surg. 2018 Oct;68(4):1135-1142.e6. doi: 10.1016/j.jvs.2017.12.071.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-04-05 10:00:002018-04-05 10:00:00Assessment of extracellular matrix-related biomarkers in patients with lower extremity artery disease

Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model

16 de March de 2018
PLoS Comput Biol. 2018 Mar 15;14(3):e1006052. doi: 10.1371/journal.pcbi.1006052.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-03-16 10:00:002018-03-16 10:00:00Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model

Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1

8 de March de 2018
Nat Commun. 2018 Mar 6;9(1):967. doi: 10.1038/s41467-018-03433-3.ABSTRACTBRCA1…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-03-08 11:00:002018-03-08 11:00:00Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1

Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells

17 de February de 2018
Carcinogenesis. 2018 Apr 5;39(4):601-613. doi: 10.1093/carcin/bgy023.ABSTRACTTargeting…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-02-17 11:00:002018-02-17 11:00:00Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells

ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

17 de February de 2018
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1216-1229. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-02-17 11:00:002018-02-17 11:00:00ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

17 de February de 2018
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1216-1229. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-02-17 11:00:002018-02-17 11:00:00ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis

6 de February de 2018
Cancer Cell. 2018 Feb 12;33(2):259-273.e7. doi: 10.1016/j.ccell.2018.01.001.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-02-06 11:00:002018-02-06 11:00:00RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis
Page 59 of 87«‹5758596061›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (8)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}